Gujarat Themis Biosyn Limited Announces EGM on August 22, 2026
Gujarat Themis Biosyn Limited will hold its EGM on August 22, 2026, in Vapi, Gujarat. The meeting will address related party transactions, Articles of Association amendments, and NCD/debt security placements. Remote e-voting is open from August 19-21, 2026, with a cut-off date of August 15, 2026.
The EGM is a standard corporate procedure to seek shareholder approval for specific resolutions, which typically has a low immediate impact on the company's stock price unless the resolutions themselves are highly unusual or controversial.
The announcement is a routine corporate event (EGM) with no immediately positive or negative financial implications mentioned.
Gujarat Themis Biosyn Limited has announced its Extra-Ordinary General Meeting (EGM) will be held on Saturday, August 22, 2026, at 12:00 Noon IST. The meeting will take place at the Registered Office of Themis Medicare Limited, located at Plot No. 69/A, GIDC Industrial Estate, Vapi - 396 195, Dist. Valsad, Gujarat, with physical presence of members. The Notice of EGM, sent on July 31, 2026, will also be available on the company's website (www.gtbl.in) and CDSL's website (www.evotingindia.com). The company is seeking member approval through remote e-voting for material related party transactions, amendments to the Articles of Association, and private placement of NCDs/debt securities.
The remote e-voting facility will be available from Wednesday, August 19, 2026, at 09:00 A.M. until Friday, August 21, 2026, at 05:00 P.M. The cut-off date for determining eligibility for remote e-voting and voting at the EGM is Saturday, August 15, 2026. Queries regarding electronic voting can be directed to CDSL via email or phone.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.